Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 149

1.

Acetylcholine and memory: a long, complex and chaotic but still living relationship.

Micheau J, Marighetto A.

Behav Brain Res. 2011 Aug 10;221(2):424-9. doi: 10.1016/j.bbr.2010.11.052. Epub 2010 Dec 3. Review.

PMID:
21130809
2.

Acetylcholine and attention.

Klinkenberg I, Sambeth A, Blokland A.

Behav Brain Res. 2011 Aug 10;221(2):430-42. doi: 10.1016/j.bbr.2010.11.033. Epub 2010 Nov 23. Review.

PMID:
21108972
3.

Transgenic mice overexpressing APP and transforming growth factor-beta1 feature cognitive and vascular hallmarks of Alzheimer's disease.

Ongali B, Nicolakakis N, Lecrux C, Aboulkassim T, Rosa-Neto P, Papadopoulos P, Tong XK, Hamel E.

Am J Pathol. 2010 Dec;177(6):3071-80. doi: 10.2353/ajpath.2010.100339. Epub 2010 Nov 18.

4.

A randomized pilot clinical trial of the safety of pioglitazone in treatment of patients with Alzheimer disease.

Geldmacher DS, Fritsch T, McClendon MJ, Landreth G.

Arch Neurol. 2011 Jan;68(1):45-50. doi: 10.1001/archneurol.2010.229. Epub 2010 Sep 13.

PMID:
20837824
5.

Rosiglitazone monotherapy in mild-to-moderate Alzheimer's disease: results from a randomized, double-blind, placebo-controlled phase III study.

Gold M, Alderton C, Zvartau-Hind M, Egginton S, Saunders AM, Irizarry M, Craft S, Landreth G, Linnamägi U, Sawchak S.

Dement Geriatr Cogn Disord. 2010;30(2):131-46. doi: 10.1159/000318845. Epub 2010 Aug 21.

6.

The Nuclear Receptor PPARgamma as a Therapeutic Target for Cerebrovascular and Brain Dysfunction in Alzheimer's Disease.

Nicolakakis N, Hamel E.

Front Aging Neurosci. 2010 May 21;2. pii: 21. doi: 10.3389/fnagi.2010.00021. eCollection 2010.

7.
8.

Revisiting the role of neurons in neurovascular coupling.

Cauli B, Hamel E.

Front Neuroenergetics. 2010 Jun 23;2:9. doi: 10.3389/fnene.2010.00009. eCollection 2010.

9.

Intact memory in TGF-β1 transgenic mice featuring chronic cerebrovascular deficit: recovery with pioglitazone.

Nicolakakis N, Aboulkassim T, Aliaga A, Tong XK, Rosa-Neto P, Hamel E.

J Cereb Blood Flow Metab. 2011 Jan;31(1):200-11. doi: 10.1038/jcbfm.2010.78. Epub 2010 Jun 23.

10.

Cortical oxygen supply during postural hypotension is further decreased in Alzheimer's disease, but unrelated to cholinesterase-inhibitor use.

van Beek AH, Sijbesma JC, Jansen RW, Rikkert MG, Claassen JA.

J Alzheimers Dis. 2010;21(2):519-26. doi: 10.3233/JAD-2010-100288.

PMID:
20555135
11.

Mitochondrial superoxide contributes to blood flow and axonal transport deficits in the Tg2576 mouse model of Alzheimer's disease.

Massaad CA, Amin SK, Hu L, Mei Y, Klann E, Pautler RG.

PLoS One. 2010 May 10;5(5):e10561. doi: 10.1371/journal.pone.0010561.

12.

Alzheimer's disease.

Querfurth HW, LaFerla FM.

N Engl J Med. 2010 Jan 28;362(4):329-44. doi: 10.1056/NEJMra0909142. Review. No abstract available. Erratum in: N Engl J Med. 2011 Feb 10;364(6):588.

PMID:
20107219
13.

Functional alterations in memory networks in early Alzheimer's disease.

Sperling RA, Dickerson BC, Pihlajamaki M, Vannini P, LaViolette PS, Vitolo OV, Hedden T, Becker JA, Rentz DM, Selkoe DJ, Johnson KA.

Neuromolecular Med. 2010 Mar;12(1):27-43. doi: 10.1007/s12017-009-8109-7. Review.

14.

Efficacy of PPAR-γ agonist pioglitazone in mild Alzheimer disease.

Sato T, Hanyu H, Hirao K, Kanetaka H, Sakurai H, Iwamoto T.

Neurobiol Aging. 2011 Sep;32(9):1626-33. doi: 10.1016/j.neurobiolaging.2009.10.009. Epub 2009 Nov 17.

PMID:
19923038
15.

Inhibition impairments in Alzheimer's disease, mild cognitive impairment and healthy aging: effect of congruency proportion in a Stroop task.

Bélanger S, Belleville S, Gauthier S.

Neuropsychologia. 2010 Jan;48(2):581-90. doi: 10.1016/j.neuropsychologia.2009.10.021. Epub 2009 Oct 30.

PMID:
19879885
16.

Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin?

Palop JJ, Mucke L.

Neuromolecular Med. 2010 Mar;12(1):48-55. doi: 10.1007/s12017-009-8097-7. Epub 2009 Oct 17. Review.

17.

Angiotensin receptor blocker prevented beta-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling.

Takeda S, Sato N, Takeuchi D, Kurinami H, Shinohara M, Niisato K, Kano M, Ogihara T, Rakugi H, Morishita R.

Hypertension. 2009 Dec;54(6):1345-52. doi: 10.1161/HYPERTENSIONAHA.109.138586. Epub 2009 Oct 5.

18.

Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice.

Tong XK, Nicolakakis N, Fernandes P, Ongali B, Brouillette J, Quirion R, Hamel E.

Neurobiol Dis. 2009 Sep;35(3):406-14. doi: 10.1016/j.nbd.2009.06.003. Epub 2009 Jun 12.

PMID:
19524673
19.

Altered cerebral hemodynamics in early Alzheimer disease: a pilot study using transcranial Doppler.

Claassen JA, Diaz-Arrastia R, Martin-Cook K, Levine BD, Zhang R.

J Alzheimers Dis. 2009;17(3):621-9. doi: 10.3233/JAD-2009-1079.

20.

The neural correlates of verbal short-term memory in Alzheimer's disease: an fMRI study.

Peters F, Collette F, Degueldre C, Sterpenich V, Majerus S, Salmon E.

Brain. 2009 Jul;132(Pt 7):1833-46. doi: 10.1093/brain/awp075. Epub 2009 May 11.

PMID:
19433442

Supplemental Content

Support Center